Par Drugs and Chemicals Ltd

PAR

Company Profile

  • Business description

    Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.

  • Contact

    Gotri Vasna Road
    815, Nilamber Triumph
    VadodaraGJ390007
    IND

    T: +91 2652991021

    https://www.pardrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    121

Stocks News & Analysis

stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.
stocks

3 cheap fully franked stocks

Discounted Aussie shares that offer a tax rebate.
stocks

SpaceX jumps 19% in debut, but hurdles lie ahead

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,134.5021.100.23%
CAC 408,350.87150.081.83%
DAX 4024,635.30425.591.76%
Dow JONES (US)51,202.26353.510.70%
FTSE 10010,471.72167.841.63%
HKSE24,829.11111.010.45%
NASDAQ25,888.8479.180.31%
Nikkei 22569,305.853,285.814.98%
NZX 50 Index13,372.4921.38-0.16%
S&P 5007,431.4637.160.50%
S&P/ASX 2008,922.8015.800.18%
SSE Composite Index4,068.5837.060.92%

Market Movers